The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study

EuroIntervention 2014;9:1264-1270 published online ahead of print October 2013. DOI: 10.4244/EIJV9I11A216

1. MonashHEART, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia; 2. Royal Adelaide Hospital, Adelaide, South Australia, Australia; 3. The Cardiovascular Research Centre, St. Vincent’s Hospital Melbourne, Melbourne, Australia; 4.

Aims: To assess outcomes with a new fully repositionable and retrievable valve for transcatheter aortic valve replacement (TAVR).

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months